The Asian Crime Century

The Asian Crime Century

Share this post

The Asian Crime Century
The Asian Crime Century
Generally Unacceptable Accounting Principles: Lessons From PwC and AstraZeneca’s Contrasting Fates

Generally Unacceptable Accounting Principles: Lessons From PwC and AstraZeneca’s Contrasting Fates

The Asian Crime Century briefing 99

Dec 07, 2024
∙ Paid
2

Share this post

The Asian Crime Century
The Asian Crime Century
Generally Unacceptable Accounting Principles: Lessons From PwC and AstraZeneca’s Contrasting Fates
1
Share
Source: China Daily

The pharmaceutical company AstraZeneca had good news from the People’s Republic of China (PRC) at the end of November, with the National Healthcare Security Administration (国家医疗保障局) pre-approving its cancer drug Enhertu for the national health insurance reimbursement list (SCMP, November 29). This news will be welcomed, as the company…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Martin Purbrick
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share